Income Statement
The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
The financial performance between 2019 and 2023 is characterized by a notable divergence between declining top-line revenues and expanding gross profitability. While net revenues peaked in 2020 at 26,153 million US$ and subsequently declined to 24,483 million US$ by 2023, gross profit consistently trended upward, rising from 12,711 million US$ in 2019 to 14,284 million US$ in 2023.
- Revenue and Margin Analysis
- A contraction in net revenues is observed starting after 2020, yet the gross profit margin improved. This was driven by a significant reduction in cost of sales, which decreased from a peak of 7,818 million US$ in 2020 to 6,218 million US$ in 2023, and a steady decline in excise taxes on products, which fell from 5,314 million US$ in 2019 to 3,981 million US$ in 2023.
- Operating Performance
- Operating income demonstrated resilience, growing from 10,326 million US$ in 2019 to a peak of 11,919 million US$ in 2022. A slight correction occurred in 2023, with operating income settling at 11,547 million US$. This stability suggests that the core operational business remained robust despite the decline in overall revenue.
- Non-Operating Volatility and Impairments
- Net earnings were subject to extreme volatility due to significant non-cash charges and investment losses. A substantial impairment of JUUL equity securities totaling 8,600 million US$ in 2019 and 2,600 million US$ in 2020, combined with losses from Cronos-related financial instruments, resulted in a net loss for 2019. Further volatility was observed in 2021 due to a 5,979 million US$ loss from investments in equity securities.
- Debt and Interest Expenses
- Interest and other debt expenses, net, show a consistent downward trend, improving from -1,280 million US$ in 2019 to -989 million US$ in 2023. This reduction in financing costs has contributed positively to the earnings before income taxes.
- Net Earnings Trajectory
- Following the stabilization of investment-related losses and the cessation of major JUUL impairments, net earnings attributable to Altria grew significantly, rising from 2,475 million US$ in 2021 to 8,130 million US$ in 2023. This recovery reflects the strength of the underlying operating income once extraordinary non-operating losses were mitigated.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?